is ostensibly stabilised in the active GTP form, is well validated and linked to over 20% of human cancers, making it a highly desirable target in oncology drug discovery. We have employed a combination of biophysical techniques as central drivers for drug discovery, interacting with medicinal chemistry to establish structure-activity relationships (SAR), increasing affinities and improving the binding kinetics of candidate small molecules targeting mutant KRas. Fragment based screens using surface plasmon resonance (SPR) and nuclear magnetic resonance (NMR) yielded a number of different chemical starting points. These initial hits, which exhibited high millimolar affinities, have evolved and grown to deliver a set of molecules that exhibit submicromolar affinity with additional help of crystallography, isothermal titration calorimetry (ITC) and computational modelling. The improved binding is also translating to functional effects in vitro in additional biochemical assays. This study demonstrates the impact of Biophysics in a critical area of cancer drug discovery and how its interplay with medicinal chemistry has developed promising compounds that aim to interrupt KRas signalling and thus decrease KRas dependent oncogenesis.
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Identification of the Flexible Regions Differentiating Ligand-Binding Affinity for Mdm2 and MdmX Zheng Su, Xiyao Cheng, Lingyun Qin, Rong Rong, Yongqi Huang. Biopharmaceutical Science, Hubei University of Technology, Wuhan, China. The interactions of p53 protein with the overexpressed mouse double minute 2 (Mdm2) and mouse double minute X (MdmX) impair the cancer suppression of p53 in approximately half of cancers. Although Mdm2 and MdmX are highly homologous, currently only Mdm2 inhibitors are available but exhibit weak affinity for MdmX. The structural mechanism underlying how the two proteins distinguish a ligand remains elusive. Here we found that the distinct difference between their ligand-binding pocket flexibilities differentiated ligand-binding affinity. Through rigidifying the ligand-binding pocket on MdmX using disulfide staples to tether flexible regions, we were able to identify the flexible regions that control ligand-binding affinity. Thus, we utilized a reversethinking strategy to transform nutlin-3a into potent MdmX inhibitors. The strategy should be applicable for lead optimization in drug discovery. Institute for Protein Research, Osaka, Japan. An increasing wave of new type 2 diabetes (T2D) cases affected millions of people worldwide and calls for new and more efficient ways of blood glucose level control. Insulin is secreted from pancreatic beta cells a process facilitated by sulfonylurea drugs. Precise dynamical control of this process is not possible yet. Photopharmacology [1] brings a promising strategy for an improved treatment of T2D. We used a range of quantum-chemical methods (HF, DFT, SAC-CI) to study the molecular and electronic structure of a prospective azobenzene-based drug JB253 [2] . We present UV-VIS and circular dichroism spectra of this compound embedded in a protein environment. We developed CHARMM force field parameters for the drug and probed, via systematic docking [3] and modeling in atomic detail, how its interactions with EPAC2A enzyme depend on the cis-trans conformations of JB253. Classical MD simulations on a nanoseconds timescale reveal that the optically activated conformational change triggers a signal transduction. However, current data and quality of protein structures are too limited to elucidate the full mechanism of the optical control of the insulin release. This work is supported by National Science Centre, Poland grants no. 2016/23/ B/ST4/01770(WN) and 2015/19/N/ST3/02171(JR).
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Repeatability of Enthalpies and Gibbs Energies of a Protein -Ligand Binding Reaction Measured by ITC Vaida Paketuryte, Vaida Linkuviene, Daumantas Matulis. Institute of Biotechnology, Vilnius, Lithuania. During the rational drug design, it is important to accurately determine the protein-ligand binding constant (the affinity or the Gibbs energy change upon binding), the enthalpy, and the entropy change upon binding. These three thermodynamic parameters of the association reaction are often determined by the isothermal titration calorimetry (ITC). Here, the repeatability of the measurement of the Gibbs energy and enthalpy of acetazolamide interaction with the recombinant human carbonic anhydrase II (CA II) was evaluated by four isothermal titration calorimetry (ITC) instrument models: PEAQ-ITC, VP-ITC, and iTC200 (manufactured by Malvern Instruments) and Affinity ITC (by TA Instruments). The protein-ligand binding reaction was repeated under identical conditions to obtain the statistical standard deviation of the measurements performed at 25 C at various protein concentration. The enthalpy and Gibbs energy mean values plus minus the standard deviation of acetazolamide binding to CA II at 10 mM and 25 C were equal to DH= À51.1 5 3.1 kJ/mol and G= À45.2 5 1.3 kJ/mol as determined by averaging the results of all four instruments and applying the NITPIC-SEDPHAT software analysis that usually reduced the standard deviation of the enthalpy. The binding of small molecules to proteins usually occurs at specific clefts or cavities on the protein surface known as binding pockets. In the past years it has become increasingly clear that binding pockets are dynamical entities, whose shape and size can change due to the intrinsic motions of the protein. In particular, some pockets open transiently, so that they can be detected only if the dynamics of the protein is taken into account. The aim of the present work is to understand how the surface and in particular the binding pockets of a protein can be modified by an external force mimicking a mechanical stress. Indeed, proteins can often be subjected to mechanical forces while performing their function, for example if they are involved in muscle contraction or cell adhesion. However, most of the single molecule studies of protein mechanics performed so far have focused on mechanical unfolding, requiring the application of forces much larger than the ones observed under physiological conditions. In this work we investigated instead the effect of low forces on the surface plasticity of proteins while they are still in their folded state. Remarkably, our Steered Molecular Dynamics simulations indicate that mechanical stress can lead to the formation of new pockets in the folded protein.
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These mechanically-induced pockets are energetically stabilised by the presence of external forces and can bind probe molecules in druggability tests. Our findings have a high potential impact on drug design, since they suggest the existence of a new class of drug targets that has not been exploited so far and that is expected to be particularly relevant for the treatment of heart and muscle diseases. This research has been supported by the British Heart Foundation.
164-Plat
Neutron Diffraction Studies of a Non-Canonical Catalytic Triad of a Less Promiscuous Aminoglycoside Acetyltransferase Fnu Prashasti. Genome Science and Technology, University of Tennessee, Knoxville, TN, USA. Bacteria can acquire resistance against antibiotics by covalently modifying them. This is achieved by plasmid-encoded enzymes called as aminoglycoside modifying enzymes (AGMEs). More than 50 AGMEs are known, having variable levels of substrate promiscuity. However, no correlation has been confirmatively observed between the sequence or structure of an AGME and its substrate profile. We aim to understand the molecular principles underlying this ligand selectivity by deciphering the thermodynamic, structural and dynamic properties of enzyme-ligand complexes.This work describes kinetic, thermodynamic and structural properties of the aminoglycoside N3 acetyltransferase VIa (AAC-VIa). AAC-VIa's substrate profile is limited to only five aminoglycosides, making it one of the least promiscuous AGMEs, despite having significant sequence similarity to other highly promiscuous acetyltransferases. X-ray crystallography studies suggested a novel catalytic mechanism involving a non-classical catalytic triad. The catalytic process was also hypothesized to involve protonated form of the active site histidine, which was demonstrated by neutron diffraction studies. Thermodynamic studies determined the binding of ligands to be enthalpically driven and entropically unfavorable. Unlike other AGMEs, the formation of binary and ternary complexes was accompanied by a net deprotonation of the enzyme, ligand or both. Another significant difference was observed in the structure of AAC-VIa and other AGMEs in solution. Analytical ultracentrifugation (AUC) studies showed that AAC-VIa exists in a monomer-dimer equilibrium, with more dimeric form appearing with increasing concentrations of the enzyme. Binding of ligands drive the enzyme to the monomeric form. Also, dimer formation, was observed to be achieved through polar interactions. Crystal structures of different complexes showed that structures of apo-and ligand-bound forms are similar which suggests that, unlike other AGMEs, more rigid structure of AAC-VIa may limit the Sunday, February 18, 2018 31a 
